Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva Braces for Tussle With Insurers Over Copaxone’s Heir
Bloomberg
Monday, March 3, 2014 - 8:28am
tags:
Teva, Copaxone, MS, multiple sclerosis, generics
Capitalizing On Cannabis: High Returns Yet Again
Seeking Alpha
Monday, March 3, 2014 - 8:17am
tags:
Medical Marijuana, ENDEXX, Cara Therapeutics, AvWorks Aviation, Vapor Group
Will Pfizer Bounce Back From Last Year’s Levoxyl Shortage?
Wall St Cheat Sheet
Monday, March 3, 2014 - 8:13am
tags:
Levoxyl, drug shortages, Pfizer, hypothyroidism
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
Forbes
Monday, March 3, 2014 - 8:12am
tags:
InterMune, Prana Biotechnology, Cara Therapeutics, Prothena, Endologix, Ampio Pharmaceuticals, Questcor Pharmaceuticals, Aegerion
Pfizer Starts Testing For Over-The-Counter Lipitor
Forbes
Monday, March 3, 2014 - 8:07am
tags:
OTC, statins, Lipitor, Pfizer
This Week in Biotech: 2 FDA Approvals and 3 Clinically Impressive Studies
Motley Fool
Sunday, March 2, 2014 - 11:59am
tags:
Myalept, leptin deficiency, lipodystrophy, Astra Zeneca, Bristol-Myers Squibb, Anika, Monovisc, osteoarthritis, osteoarthritis of the knee
Pharmaceutical company to pay NC $1.5 million for fraud
WNCN, NC
Saturday, March 1, 2014 - 12:25pm
tags:
Endo, legal
Merck: DOJ Ends Bribery Probe
WSJ
Saturday, March 1, 2014 - 12:24pm
tags:
Merck, legal
Is 2014 Going to Be GlaxoSmithKline's Year?
Motley Fool
Saturday, March 1, 2014 - 12:18pm
tags:
GSK
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results
Seeking Alpha
Saturday, March 1, 2014 - 11:58am
tags:
Alzheimer's disease, Prana Biotechnology, PBT2
Pharma Patent Cliff: Why Worst Seems Over
Seeking Alpha
Saturday, March 1, 2014 - 11:56am
tags:
patent cliff, generics
An Update On Acadia Pharmaceuticals
Seeking Alpha
Saturday, March 1, 2014 - 11:54am
tags:
Acadia
Activist Investors Agitating Biotechs Bring Multi-Bagger Returns
Motley Fool
Saturday, March 1, 2014 - 11:53am
tags:
InterMune Stuns Markets, but Is It Overvalued?
Motley Fool
Saturday, March 1, 2014 - 11:51am
tags:
InterMune
Arena Prescription Sales Up: Stops Stock Slide
Seeking Alpha
Saturday, March 1, 2014 - 11:50am
tags:
Arena Pharmaceuticals
3 Stocks Improving Performance Of The Drugs Industry
TheStreet.com
Friday, February 28, 2014 - 12:19pm
tags:
Celgene, Merck, JNJ
Report: Novartis reorganization quietly claims 3,000 jobs in just 4 months
Fierce Biotech
Friday, February 28, 2014 - 12:14pm
tags:
Novartis, layoffs, reorganization
Analysts cheer on Merck's comeback campaign, pumping up blockbuster forecasts
Fierce Biotech
Friday, February 28, 2014 - 12:13pm
tags:
Merck, MK-3475
Endo loss widens, R&D chief departs amid regulatory struggles
Fierce Pharma
Friday, February 28, 2014 - 12:11pm
tags:
Endo Health Solutions, earnings
Questcor continues lower as FDA says reviewing Acthar lab test results
The Fly on the Wall
Friday, February 28, 2014 - 11:58am
tags:
Questcor Pharmaceuticals, FDA, Acthar

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.